Boston Scientific's Watchman shows low stroke rate in large registry at ACC

Boston Scientific's Watchman device to prevent blood clots in atrial fibrillation patients was associated with low rates of stroke in a large registry analysis, offering reassurance of its effectiveness in high-risk recipients, researchers said.